SpringWorks Therapeutics (SWTX) Revenue & Revenue Breakdown
SpringWorks Therapeutics Revenue Highlights
Latest Revenue (Y)
$191.59M
Latest Revenue (Q)
$61.55M
SpringWorks Therapeutics Revenue by Period
SpringWorks Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $191.59M | 3417.33% |
| 2023-12-31 | $5.45M | -11.39% |
| 2022-12-31 | $6.15M | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2020-12-31 | $35.00M | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
SpringWorks Therapeutics generated $191.59M in revenue during NA 2024, up 3417.33% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
SpringWorks Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $61.55M | 24.84% |
| 2024-09-30 | $49.30M | -17.46% |
| 2024-06-30 | $59.73M | 184.36% |
| 2024-03-31 | $21.01M | 285.64% |
| 2023-12-31 | $5.45M | -2.49% |
| 2023-09-30 | $5.59M | -4.15% |
| 2023-06-30 | $5.83M | 4.88% |
| 2023-03-31 | $5.56M | -4.17% |
| 2022-12-31 | $5.80M | 592.00% |
| 2022-09-30 | $838.00K | 140.80% |
| 2022-06-30 | $348.00K | 6860.00% |
| 2022-03-31 | $5.00K | 100.00% |
| 2021-12-31 | - | -100.00% |
| 2021-09-30 | $121.00K | -28.82% |
| 2021-06-30 | $170.00K | -26.09% |
| 2021-03-31 | $230.00K | -99.34% |
| 2020-12-31 | $35.00M | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | - |
SpringWorks Therapeutics generated $61.55M in revenue during Q4 2024, up 24.84% compared to the previous quarter, and up 1101.84% compared to the same period a year ago.
SpringWorks Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| SWTX | SpringWorks Therapeutics | $191.59M | $61.55M |
| OPT | Opthea | $108.41K | $61.27K |